News

Fleet Bioprocessing has successfully been re-certified as meeting the standards of Cyber Essentials. Cyber Essentials is a Government backed scheme designed by the National Cyber Security Centre. By meeting the standards of Cyber Essentials, an organisation demonstrates that the defenses and controls in place will effectively protect against the vast majority of common cyber attacks.

Most of Fleet Bioprocessing Ltd.'s work is carried out under confidentiality agreements for commercial partners, therefore it never sees the light of day in publications. So we like to publicise it when our work does enter the public domain. Recently Fleet have been part of a team working with Somnus Scientific, Life Science Group, Creonate Manufacturing and AccentBio to develop immunoassays for propofol, which is a commonly-used anaesthetic for hospital procedures. It is adm

As of January 2025, the UK government has provided updated guidance on the regulatory requirements for in vitro diagnostic medical devices (IVDs) concerning UK Conformity Assessed (UKCA) marking. This guidance outlines the transitional arrangements and timelines for the acceptance of CE-marked IVDs on the Great Britain market, as well as the implementation of future regulations. Transitional Arrangements for CE-Marked IVDs To ensure a smooth transition and continuous supply o

Further to our successful audit by NQA last month, we have now received our new certificates for ISO9001: 2015 and ISO13485: 2016, which are valid until 30th November 2027. You can download copies of these certificates here: https://www.fleetbioprocessing.co.uk/quality-gmp

Our MD Alastair Dent will be attending this year's SEHTA International MedTech Expo and Conference in London on Friday 1st November, feel free to get in touch via our website contact form if you'd like a meeting. https://www.fleetbioprocessing.co.uk/contact-us

We're delighted to report that our three-day recertification audit by NQA went very well last week, with not a single non-conformance or opportunity for improvement identified by the auditor. On the basis of this inspection, Fleet Bioprocessing Ltd. has been recommended for recertification to both ISO9001: 2015 and ISO13485: 2016 until November 2027 - which will take us to 27 years of uninterrupted compliance! For the first time ISO9001 compliance now requires companies like